Abstract
Von Hippel-Lindau disease (VHL) is a rare hereditary cancer syndrome. The prevalence is estimated at 1 in 85,000 with an incidence of 1 in 45,500 live births (Friedrich 2001).
References
Bausch, B., Jilg, C., Gläsker, S., et al. (2013). Renal cancer in von Hippel–Lindau disease and related syndromes. Nature Reviews. Nephrology, 9, 529–538.
Binderup, M. L. M., Jensen, A. M., Budtz-Jørgensen, E., et al. (2016). Survival and causes of death in patients with von Hippel-Lindau disease. Journal of Medical Genetics, 0, 1–8.
Cassol, C., & Mete, O. (2015). Endocrine manifestations of von Hippel–Lindau disease. Archives of Pathology & Laboratory Medicine, 139, 263–268.
Charlesworth, M., Verbecke, C. S., Falk, G. A., et al. (2012). Pancreatic lesions in von Hippel–Lindau disease? A systematic review and meta-synthesis of the literature. Journal of Gastrointestinal Surgery, 16, 1422–1428.
Choyke, P. L., Glenn, G. M., Walther, M. M., et al. (1995). Von Hippel-Lindau disease: Genetic, clinical, and imaging features. Radiology, 194, 629–642.
Clifford, S. C., & Maher, E. R. (2001). Von Hippel-Lindau disease: Clinical and molecular perspectives. Advances in Cancer Research, 82, 85–105.
Couch, V., Lindor, N. M., Karnes, P. S., et al. (2000). Von Hippel-Lindau disease. Mayo Clinic Proceedings, 75, 265–272.
Dannenberg, H., De Krijger, R. R., van der Harst, E., et al. (2003). Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas. International Journal of Cancer, 105, 190–195.
Decker, H. J., Klauck, S. M., Lawrence, J. B., et al. (1994). Cytogenetic and fluorescence in situ hybridization studies on sporadic and hereditary tumors associated with von Hippel-Lindau syndrome (VHL). Cancer Genetics and Cytogenetics, 77, 1–13.
Dollfus, H., Massin, P., Taupin, P., et al. (2002). Retinal hemangioblastoma in von Hippel-Lindau disease: A clinical and molecular study. Investigative Ophthalmology & Visual Science, 43, 3067–3074.
Findeis-Hosey, J. J., McMahon, K. Q., & Findeis, S. K. (2016). Von Hippel-Lindau disease. Journal of Pediatric genetics, 5, 116–123.
Frantzen, C., Klasson, T. D., Links, T. P., et al. (2015). Von Hippel-Lindau syndrome. GeneReviews. Updated August 6, 2015. Available at: https://www.ncbi.nlm.nih.gov/books/NBK1463/
Friedrich, C. A. (2001). Genotype-phenotype correlation in von Hippel-Lindau syndrome. Human Molecular Genetics, 10, 763–767.
Glenn, G. M., Linehan, W. M., Hosoe, S., et al. (1992). Screening for von Hippel-Lindau disease by DNA polymorphism analysis. Journal of the American Medical Association, 267, 1226–1231.
Hammel, P. R., Vilgrain, V., Terris, B., et al. (2000). Pancreatic involvement in von Hippel-Lindau disease. Gastroenterology, 119, 1087–1095.
Hayden, M. G., Gephart, R., Kalanithi, P., et al. (2009). Von Hippel-Lindau disease in pregnancy: A brief review. Journal of Clinical Neuroscience, 16, 611–613.
Hes, F. J., Hoppener, J. W., & Lips, C. J. (2003). Clinical review 155: Pheochromocytoma in Von Hippel-Lindau disease. Journal of Clinical Endocrinology and Metabolism, 88, 969–974.
Hodgson, T. S., Nielsen, S. M., Lesniak, M. S., et al. (2016). Neurological management of von Hippel-Lindau disease. The Neurologist, 21, 73–78.
Jordan, D. K., Patil, S. R., Divelbiss, J. E., et al. (1989). Cytogenetic abnormalities in tumors of patients with von Hippel-Lindau disease. Cancer Genetics and Cytogenetics, 42, 227–241.
Kaelin Jr., W. G. (2003). The von Hippel-Lindau gene, kidney cancer, and oxygen sensing. Journal of the American Society of Nephrology, 14, 2703–2711.
Khan, A. N. (2015). Imaging in Von Hippel-Lindau syndrome. eMedicine from WebMD. Updated November 15, 2015. From http://emedicine.medscape.com/article/385704-overview
Latif, F., Tory, K., Gnarra, J., et al. (1993). Identification of the von Hippel-Lindau disease tumor suppressor gene. Science, 260, 1317–1320.
Lee, J.-S., Lee, J.-H., Lee, K. e., et al. (2016). Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-α binding site missense mutations elevate age-specific risk for CNS hemangioblastoma. BMC Medical Genetics, 17, 1–8.
Leung, R. S., Biswas, S. V., Duncan, M., et al. (2008). Imaging features of von Hippel-Lindau disease. Radiographics, 28, 65–79.
Lubensky, I. A., Pack, S., Ault, D., et al. (1998). Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients. Histopathological and molecular genetic analysis. American Journal of Pathology, 153, 223–231.
Maher, E. R., Yates, J. R., Harries, R., et al. (1990). Clinical features and natural history of von Hippel-Lindau disease. The Quarterly Journal of Medicine, 77, 1151–1163.
Murgia, A., Martella, M., Vinanzi, C., et al. (2000). Somatic mosaicism in von Hippel-Lindau disease. Human Mutation, 15, 114–119.
Neumann, H. P., & Bender, B. U. (1998). Genotype-phenotype correlations in von Hippel-Lindau disease. Journal of Internal Medicine, 243, 541–545.
Neumann, H. P., Berger, D. P., Sigmund, G., et al. (1993). Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. The New England Journal of Medicine, 329, 1531–1538.
Neumann, H. P., Lips, C. J., Hsia, Y. E., et al. (1995). Von Hippel-Lindau syndrome. Brain Pathology, 5, 181–193.
Neumann, H. P., Bender, B. U., Berger, D. P, et al. (1998). Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma. Journal of Urology, 160, 1248–1254.
Pack, S. D., Zbar, B., Pak, E., et al. (1999). Constitutional von Hippel-Lindau (VHL) gene deletions detected in VHL families by fluorescence in situ hybridization. Cancer Research, 59, 5560–5564.
Papadakis, G. Z., Millo, C., Sadowski, S. M., et al. (2016a). Endolymphatic sac tumor showing increased activity on 68Ga DOTATATE PET/CT. Clinical Nuclear Medicine, 41, 783–784.
Papadakis, G. Z., Millo, C., Sadowski, S. M., et al. (2016b). Epididymal cystadenomas in von Hippel-Lindau disease showing increased activity on 68Ga DOTATATE PET/CT. Clinical Nuclear Medicine, 41, 781–782.
Paulsen, M. L. M., Gimsing, S., Kosteljanetz, M., et al. (2011). von Hippel-Lindau disease: Surveillance strategy for endolymphatic sac tumors. Genetics in Medicine, 13, 1032–1041.
Rechitsky, S., Verlinsky, O., Chistokhina, A., et al. (2002). Preimplantation genetic diagnosis for cancer predisposition. Reproductive Biomedicine Online, 5, 148–155.
Richard, S. (2003). Von Hippel-Lindau disease: Recent advances and therapeutic perspectives. Expert Review of Anticancer Therapy, 3, 215–233.
Richard, S., David, P., Marsot-Dupuch, K., et al. (2000). Central nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease. Neurosurgical Review, 23, 1–22 discussion 23–24.
Richard, S., Gardie, B., Couve, S., et al. (2013). Von Hippel–Lindau: How a rare disease illuminates cancer biology. Seminars in Cancer Biology, 23, 26–37.
Richards, F. M., Webster, A. R., McMahon, R., et al. (1998). Molecular genetic analysis of von Hippel-Lindau disease. Journal of Internal Medicine, 243, 527–533.
Sanfilippo, P., Troutbeck, R., & Vandeleur, K. (2003). Retinal angioma associated with von Hippel-Lindau disease. Clinical and Experimental Optometry, 86, 187–191.
Sano, T., & Horiguchi, H. (2003). Von Hippel-Lindau disease. Microscopy Research and Technique, 60, 159–164.
Schunemann, V., Huntoon, K., & Lonser, R. R. (2016). Personalized medicine for nervous system manifestations of von Hippel–Lindau Disease. Frontiers in Surgery, 3, 1–5.
Schimke, R. N., Collins, D. L., & Stolle, C. A. (2009). Von Hippel-Lindau syndrome. GeneReviews. Updated December 22, 2009. http://www.ncbi.nlm.nih.gov/books/NBK1463/
Sgambati, M. T., Stolle, C., Choyke, P. L., et al. (2000). Mosaicism in von Hippel-Lindau disease: Lessons from kindreds with germline mutations identified in offspring with mosaic parents. American Journal of Human Genetics, 66, 84–91.
Shanbhogue, K. P., Hoch, M., Fatterpaker, G., et al. (2016). Von Hippel-Lindau disease: Review of genetics and imaging. Radiology Clinics of North America, 54, 409–422.
Shenoy, N., & Pagliaro, L. (2016). Sequential pathogenesis of metastatic VHL mutant clear cell renal cell carcinoma: putting it together with a translational perspective. Annals of Oncology, 27, 1685–1695.
Simpson, J. L., Carson, S. A., & Cisneros, P. (2005). Preimplantation genetic diagnosis (PGD) for heritable neoplasia. Journal of National Cancer Institute. Monographs, 34, 87–90.
Stolle, C., Glenn, G., Zbar, B., et al. (1998). Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Human Mutation, 12, 417–423.
Suzuki, H., Kakurai, K., Morishita, S., et al. (2016). Vitrectomy for tractional retinal detachment with twin retinal capillary hemangiomas in a patient with von Hippel-Lindau disease: a case report. Case Reports in Ophthalmology, 7, 333–340.
Tamura, K., Nishimori, I., Ito, T., et al. (2010). Diagnosis and management of pancreatic neuroendocrine tumor in von Hippel-Lindau disease. World Journal of Gastroenterology, 16, 4515–4518.
Taouli, B., Ghouadni, M., Correas, J. M., et al. (2003). Spectrum of abdominal imaging findings in von Hippel-Lindau disease. AJR. American Journal of Roentgenology, 181, 1049–1054.
Torreggiani, W. C., Keogh, C., Al-Ismail, K., et al. (2002). Von Hippel-Lindau disease: A radiological essay. Clinical Radiology, 57, 670–680.
Wind, J. J., Bakhtian, K. D., Sweet, J. A., et al. (2011). Long-term outcome after resection of brainstem hemangioblastomas in von Hippel-Lindau disease. Journal of Neurosurgery, 114, 1312–1318.
Wizigmann-Voos, S., & Plat, K. H. (1996). Pathology, genetics and cell biology of hemangioblastomas. Histology and Histopathology, 11, 1049–1061.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media LLC
About this entry
Cite this entry
Chen, H. (2016). Von Hippel-Lindau Disease. In: Atlas of Genetic Diagnosis and Counseling. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6430-3_243-2
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6430-3_243-2
Received:
Accepted:
Published:
Publisher Name: Springer, New York, NY
Online ISBN: 978-1-4614-6430-3
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences